Showing 2261-2270 of 2739 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21171/Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuUpdate on Pediatric Psoriasis
https://practicaldermatology.com/columns/clinical-focus-1/update-on-pediatric-psoriasis/23358/New guidelines and new treatments seek to dramatically improve lives of children with psoriasis.Herbals in the Holistic Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/herbals-in-the-holistic-treatment-of-psoriasis/21055/Dermatologists must be aware of the herbal supplements patients may take and their potential effects.New Products and Therapeutic Focus: Lasers
https://practicaldermatology.com/columns/new-products/new-products-and-therapeutic-focus-lasers/21089/New Products
https://practicaldermatology.com/topics/practice-management/new-products/21183/Raising Issues with MOC
https://practicaldermatology.com/topics/practice-management/raising-issues-with-moc/21195/Dermatologists and the AAD speak out against current MOC requirements and suggest changes.New Products
https://practicaldermatology.com/columns/new-products/new-products/21250/New products and pharmacologic developmentsThe Melanoma Pipeline
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-melanoma-pipeline/21400/A closer look at the latest data for two investigational agents that have made headlines.EHR User Series—Part III
https://practicaldermatology.com/topics/practice-management/ehr-user-seriespart-iii/21509/A Q&A series with clinicians about their experience and broader impressions of EHRs in dermatology.